{"schema_version":"secwatch.filing_event.v1","accession":"0001636422-24-000116","form_type":"8-K","ticker":"HCAT","cik":"0001636422","company_name":"Health Catalyst, Inc.","filed_at":"2024-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.899041+00:00","generated_at":"2026-05-31T11:47:35.301096+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Health Catalyst beats Q2 2024 guidance: revenue $75.9M, Adj. EBITDA $7.5M","bullets":["Total revenue $75.9M (+4% YoY); net loss $13.5M vs $32.6M loss in Q2 2023.","Adjusted EBITDA $7.5M, exceeding guidance midpoint of $6.0M.","Reiterates FY 2024 revenue $304-312M and Adj. EBITDA $24-26M; Q3 rev guidance $74.5-77.5M.","Signed more net new platform subscription clients in 1H 2024 than all of 2023; targeting low-20s for FY.","Announced $225M credit facility with Silver Point Finance and acquisitions of Carevive and Lumeon."],"urls":{"canonical":"https://secwatch.observer/filing/0001636422-24-000116","json":"https://secwatch.observer/filing/0001636422-24-000116.json","markdown":"https://secwatch.observer/filing/0001636422-24-000116.md","text":"https://secwatch.observer/filing/0001636422-24-000116.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636422/000163642224000116/0001636422-24-000116-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636422/000163642224000116/hcat-20240807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:47:35.301096+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}